Bruker Corporation updates financial guidance for the full year of 2024. For the period, the company expects increases revenues of $3.38 to $3.44 billion, compared to fiscal 2023 revenues of $2.96 billion, with 14% to 16% year-over-year reported revenue growth, including contributions from: organic revenue growth of 5% to 7%. Updated guidance now includes the operational and financing impact of the NanoString acquisition, as well as all other closed acquisitions.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
64.73 USD | +1.16% | -0.95% | -11.91% |
- Stock Market
- Equities
- BRKR Stock
- News Bruker Corporation
- Bruker Corporation Updates Financial Guidance for the Full Year of 2024